Patent Assignment
Reel/Frame 061419/0029
Assignment of Assignor's Interest
Recorded: 2022-10-13
Pages: 3
Assignor
DAVIS, JEFFERSON E.
Executed: 2022-10-10
Assignee
ACER THERAPEUTICS, INC.
300 WASHINGTON STREET, ONE GATEWAY CENTER, SUITE 351, NEWTON, MASSACHUSETTS, 02458
Covered Property
(1)
Nk Receptor Antagonists for Treatment of Prostate Cancer
Application:
63/305,209 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 11, 2022
From: ACER THERAPEUTICS INC.
To: SWK FUNDING LLC
Reel/Frame 059237/0638 →
Security Interest
Jul 6, 2023
From: SWK FUNDING LLC; ACER THERAPEUTICS INC
To: NANTAHALA CAPITAL MANAGEMENT, LLC
Reel/Frame 064167/0828 →
Release of Security Interest
Apr 5, 2024
From: ZEVRA THERAPEUTICS INC. (AS SUCCESSOR IN INTEREST TO NANTAHALA CAPITAL MANAGEMENT, LLC, AS SUCCESSOR IN INTEREST TO SWK FUNDING LLC)
To: ACER THERAPEUTICS INC.
Reel/Frame 067020/0036 →